Celltrion
068270.KS
#708
Rank
NZ$49.17 B
Marketcap
$225.29
Share price
1.08%
Change (1 day)
1.85%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.92

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $5.24. In 2022 the company made an earnings per share (EPS) of $5.10 a decrease over its 2021 EPS that were of $6.07.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.92-3.63%
2022$5.10-15.84%
2021$6.0712.77%
2020$5.3870.79%
2019$3.1515.63%
2018$2.72-33.13%
2017$4.07141.17%
2016$1.698.28%
2015$1.5611.28%
2014$1.4016.37%
2013$1.20-67.42%
2012$3.7084.22%
2011$2.0162.13%
2010$1.2480.61%
2009$0.69-559.63%
2008-$0.15-123.16%
2007$0.64